Definium Therapeutics Inc. Common Shares vs Invesco WilderHill Clean Energy ETF — how do they compare? Definium Therapeutics Inc. Common Shares trades at $34.01 (market cap $4.71B), while Invesco WilderHill Clean Energy ETF trades at $28.29 (market cap $347.46M). The key difference: Definium Therapeutics Inc. Common Shares is far larger — about 13.6× Invesco WilderHill Clean Energy ETF's market cap, and Definium Therapeutics Inc. Common Shares is trading nearer its 52-week high, Invesco WilderHill Clean Energy ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Invesco WilderHill Clean Energy ETF for 46 Days on average.
| DFTX | PBW | |
|---|---|---|
Market Cap | $4.71B | $347.46M |
Volume | 1,966,636 | 413,698 |
Sector | Health | Sector/Thematic |
52-Week High | $48.45 | $46.99 |
52-Week Low | $10.68 | $28.29 |
Typical Hold Time | 0 Days | 46 Days |
Enterprise Value | $3.67B | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
PBW, the Invesco WilderHill Clean Energy ETF, trades at $28.92, down 2.89% today amid a bearish technical signal from moving averages. The ETF's unique selection criteria prioritize ecological factors over financial metrics, resulting in concentrated exposure to the clean energy sector. Recent institutional selling, including a 96.3% reduction by IFP Advisors Inc. in Q2 2026 (SEC filing, September 18, 2026), reflects cautious sentiment despite long-term growth drivers like energy security and data center demand.
Outlook remains challenged by near-term volatility and sector underperformance versus broad markets, though global investment in clean energy offers structural tailwinds. Key risks include oil price swings, Fed policy impacts, and lack of diversification. Investors face a trade-off between speculative growth potential and elevated sensitivity to macroeconomic shifts.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →PBW is an equal-weighted ETF that invests in U.S. companies leading the clean energy transition. It focuses on renewable energy, power conservation, and sustainable technologies like solar, wind, and energy storage.
Read more on PBW →